Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154).

Source:http://linkedlifedata.com/resource/pubmed/id/12201361

Download in:

View as

General Info

PMID
12201361